The Basel Institute’s Collective Action team has facilitated the co-development of a set of indicators that health care companies may wish to consider when reporting on the effectiveness of their anti-corruption efforts to external stakeholders.

The guidance note containing the indicators was developed over seven months by a group of health care companies under an innovative project of Norges Bank Investment Management.

This guidance note contains a set of indicators that companies may wish to consider when reporting on the effectiveness of their anti-corruption efforts to external stakeholders. Such disclosures could also be useful to build trust with external stakeholders, mitigate reputational risk and identify best practices.

It is focused on the health sector, which is especially vulnerable to compliance risks because of the complexity of its value chain and the size of the financial flows in the sector.

This paper sets out why and how Collective Action needs to become a global "norm" in the fight against corruption and an integral part of mainstream anti-corruption efforts. The idea is to ensure that Collective Action is considered in companies' compliance programmes as a risk mitigation tool to analyse and address persistent problems of corruption. The pathway to achieving this is to embed Collective Action as recommendation in international, national and business-relevant standards.

The report: 

This report emerges from the Basel Institute's Green Corruption programme, a multi-disciplinary engagement that targets environmental degradation through tested anti-corruption, asset recovery and governance methods. It was funded by PMI Impact as part of a wider project on intelligence-led on financial crime in illegal wildlife trade (IWT).

This toolkit provides a starting point for all parties interested in bringing together the various stakeholders associated with customs clearance procedures, and to support the development of a practical set of activities and documentation that will reduce the risks of the supply and demand sides of bribery to which customs brokers may be subject. 

The target audience for this toolkit is government authorities (Customs administrations), customs brokers and their customers, and civil society.

As aid, donations and recovery packages are deployed to cope with the pandemic, the risk of corruption is surging in many countries. Funds for emergency healthcare procurements are flooding in. These fast procurement processes often have limited corruption prevention measures in place and therefore present an increased risk for both governments and businesses.

Written inputs to inform the Human Rights Council

This note provides written inputs on question 4 and question 5 of the call for inputs published by the United Nations Human Rights Council Working Group on Business and Human Rights. It relates to the February 2020 multi-stakeholder consultation on connecting the business and human rights and anti-corruption agendas.

Report of the Working Group on the issue of human rights and transnational corporations and other business enterprises

This report was prepared pursuant to United Nations Human Rights Council resolutions 17/4 and 35/7. It was presented at the forty-fourth session of the Human Rights Council on 15 June–3 July 2020 during agenda item 3: Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development.